BMY |
Bristol-Myers Squibb Company |
113.30B |
8.87% |
|
|
|
|
|
55.83 |
0.07% |
28.93% |
31.18% |
---|
PFE |
Pfizer Inc. |
149.04B |
7.20% |
|
|
|
|
|
26.30 |
1.54% |
29.55% |
69.99% |
---|
ABBV |
AbbVie Inc. |
356.74B |
7.09% |
|
|
|
|
|
202.08 |
0.60% |
22.17% |
32.62% |
---|
JNJ |
Johnson & Johnson |
390.76B |
6.83% |
|
|
|
|
|
162.30 |
1.64% |
18.93% |
38.45% |
---|
MRK |
Merck & Co., Inc. |
226.40B |
6.56% |
|
|
|
|
|
89.50 |
2.08% |
29.16% |
71.04% |
---|
GILD |
Gilead Sciences, Inc. |
137.03B |
4.60% |
|
|
|
|
|
109.95 |
-0.07% |
25.23% |
31.39% |
---|
CAH |
Cardinal Health, Inc. |
30.69B |
4.13% |
|
|
|
|
|
127.06 |
-0.25% |
22.39% |
26.75% |
---|
VTRS |
Viatris Inc. |
13.43B |
4.05% |
|
|
|
|
|
11.25 |
1.72% |
30.87% |
85.75% |
---|
UTHR |
United Therapeutics Corporation |
16.12B |
3.75% |
|
|
|
|
|
361.10 |
-1.70% |
35.09% |
97.66% |
---|
JAZZ |
Jazz Pharmaceuticals plc |
8.22B |
3.56% |
|
|
|
|
|
136.01 |
-0.47% |
31.17% |
68.24% |
---|
ZTS |
Zoetis Inc. |
71.85B |
3.49% |
|
|
|
|
|
160.46 |
1.93% |
29.70% |
11.53% |
---|
LLY |
Eli Lilly and Company |
829.40B |
3.19% |
|
|
|
|
|
873.68 |
0.06% |
29.54% |
16.87% |
---|
AMGN |
Amgen Inc. |
162.78B |
3.07% |
|
|
|
|
|
303.01 |
1.71% |
21.37% |
8.26% |
---|
BIIB |
Biogen Inc. |
20.59B |
2.90% |
|
|
|
|
|
140.64 |
2.59% |
37.81% |
56.88% |
---|
OGN |
Organon & Co. |
3.99B |
2.42% |
|
|
|
|
|
15.49 |
-1.27% |
45.12% |
37.21% |
---|
CRL |
Charles River Laboratories International... |
8.34B |
2.40% |
|
|
|
|
|
163.02 |
0.47% |
44.67% |
44.83% |
---|
REGN |
Regeneron Pharmaceuticals, Inc. |
75.29B |
2.34% |
|
|
|
|
|
700.33 |
0.62% |
36.18% |
59.68% |
---|
MEDP |
Medpace Holdings, Inc. |
10.37B |
1.86% |
|
|
|
|
|
340.22 |
-1.34% |
56.20% |
27.67% |
---|
NBIX |
Neurocrine Biosciences, Inc. |
12.03B |
1.61% |
|
|
|
|
|
120.69 |
3.94% |
34.71% |
22.61% |
---|
ELAN |
Elanco Animal Health Incorporated |
5.45B |
1.60% |
|
|
|
|
|
11.02 |
-0.99% |
53.28% |
62.37% |
---|
ALKS |
Alkermes plc |
5.74B |
1.13% |
|
|
|
|
|
35.32 |
-0.51% |
55.46% |
54.71% |
---|
EXEL |
Exelixis, Inc. |
10.31B |
1.12% |
|
|
|
|
|
36.85 |
5.02% |
35.76% |
27.34% |
---|
HALO |
Halozyme Therapeutics, Inc. |
7.11B |
1.10% |
|
|
|
|
|
57.75 |
0.54% |
37.56% |
45.45% |
---|
PBH |
Prestige Consumer Healthcare Inc. |
4.19B |
0.95% |
|
|
|
|
|
84.63 |
-0.19% |
28.23% |
56.49% |
---|
PRGO |
Perrigo Company plc |
3.46B |
0.95% |
|
|
|
|
|
25.34 |
0.40% |
43.05% |
86.08% |
---|
CORT |
Corcept Therapeutics Incorporated |
6.66B |
0.79% |
|
|
|
|
|
63.54 |
-2.38% |
65.42% |
61.91% |
---|
TGTX |
TG Therapeutics, Inc. |
4.81B |
0.74% |
|
|
|
|
|
30.88 |
-0.19% |
81.07% |
55.79% |
---|
PTGX |
Protagonist Therapeutics, Inc. |
2.31B |
0.69% |
|
|
|
|
|
38.75 |
0.68% |
68.70% |
84.70% |
---|
ACLX |
Arcellx, Inc. |
3.45B |
0.63% |
|
|
|
|
|
63.75 |
-2.83% |
46.12% |
25.56% |
---|
ITCI |
Intra-Cellular Therapies, Inc. |
13.67B |
0.63% |
|
|
|
|
|
128.60 |
0.05% |
11.93% |
15.81% |
---|
ALNY |
Alnylam Pharmaceuticals, Inc. |
32.44B |
0.62% |
|
|
|
|
|
250.59 |
-0.16% |
41.52% |
33.50% |
---|
TWST |
Twist Bioscience Corporation |
2.46B |
0.60% |
|
|
|
|
|
41.31 |
-8.36% |
66.71% |
12.18% |
---|
VCEL |
Vericel Corporation |
2.57B |
0.59% |
|
|
|
|
|
52.00 |
-4.25% |
58.27% |
68.59% |
---|
INCY |
Incyte Corporation |
13.96B |
0.57% |
|
|
|
|
|
72.11 |
1.02% |
42.37% |
83.22% |
---|
ADMA |
ADMA Biologics, Inc. |
3.74B |
0.55% |
|
|
|
|
|
15.84 |
-1.49% |
61.47% |
19.44% |
---|
ACAD |
ACADIA Pharmaceuticals Inc. |
3.32B |
0.55% |
|
|
|
|
|
19.95 |
-1.68% |
52.38% |
52.95% |
---|
ROIV |
Roivant Sciences Ltd. |
7.62B |
0.51% |
|
|
|
|
|
10.68 |
-0.37% |
32.36% |
68.47% |
---|
EXAS |
Exact Sciences Corporation |
9.12B |
0.50% |
|
|
|
|
|
49.26 |
-0.50% |
63.70% |
17.62% |
---|
BPMC |
Blueprint Medicines Corporation |
5.90B |
0.50% |
|
|
|
|
|
92.25 |
-2.23% |
66.68% |
15.72% |
---|
AMRX |
Amneal Pharmaceuticals, Inc. |
3.62B |
0.50% |
|
|
|
|
|
7.83 |
-0.51% |
67.35% |
30.43% |
---|
INSM |
Insmed Incorporated |
14.50B |
0.49% |
|
|
|
|
|
81.06 |
-3.05% |
46.27% |
4.03% |
---|
SRPT |
Sarepta Therapeutics, Inc. |
10.15B |
0.49% |
|
|
|
|
|
106.28 |
-1.96% |
49.27% |
16.33% |
---|
KRYS |
Krystal Biotech, Inc. |
5.40B |
0.45% |
|
|
|
|
|
187.86 |
2.87% |
46.99% |
31.69% |
---|
KYMR |
Kymera Therapeutics, Inc. |
2.38B |
0.45% |
|
|
|
|
|
36.81 |
-1.63% |
67.60% |
98.16% |
---|
BMRN |
BioMarin Pharmaceutical Inc. |
13.01B |
0.44% |
|
|
|
|
|
68.25 |
-0.70% |
33.04% |
28.31% |
---|
VRTX |
Vertex Pharmaceuticals Incorporated |
124.35B |
0.44% |
|
|
|
|
|
484.24 |
0.81% |
29.71% |
30.05% |
---|
IONS |
Ionis Pharmaceuticals, Inc. |
5.10B |
0.40% |
|
|
|
|
|
32.32 |
-1.13% |
57.02% |
68.51% |
---|
RNA |
Avidity Biosciences, Inc. |
3.71B |
0.36% |
|
|
|
|
|
31.12 |
-4.33% |
67.15% |
32.35% |
---|
VKTX |
Viking Therapeutics, Inc. |
3.80B |
0.34% |
|
|
|
|
|
34.07 |
7.71% |
105.49% |
45.52% |
---|
MYGN |
Myriad Genetics, Inc. |
1.29B |
0.26% |
|
|
|
|
|
14.18 |
-5.34% |
60.35% |
59.69% |
---|
|
US Dollar |
|
0.13% |
|
|
|
|
|
|
|
|
|
---|